Forgot your password?

Forgot your username?

database > resource

LifeTech Capital

4431 Woodfield Blvd.
Boca Raton, Fl 33432
561-988-9129
561-988-9129
www.lifetechcapital.com
Abstract Description
A multi-disciplinary team of investment professionals.
Management
Stephen M. Dunn, President & Senior Managing Director of Research; William D. Dawson, Senior Vice President of Research

Keywords
institutional research, capital, 2010 OneMedForum sponsor, investment banking, capital markets, accredited investors, Aurora Capital,
Comment  |  Printable Version   | 1 of 1 |   |
//

Description

LifeTech Capital is a multi-disciplinary team of investment professionals specializing in serving the unique needs of the biotechnology, medical technology and life technology (air-food-water) industries and investor community.

Program/Products/Services

Institutional Research, Investment Banking, Capital Markets, Accredited Investors

Points of Differentiation

Our institutional research team provides exceptional industry insight into the complex analysis of determining the potential future value of drugs, devices and companies as well as access to leading key opinion leaders. With international media exposure and public appearances at both scientific and financial events, our institutional research team assists companies and investors in unlocking the value of science.

We understand that promising companies require significant capital to successfully unlock the value of science. LifeTech Capital's investment banking team and capital markets team is knowledgeable in both the industry and Wall Street and develops appropriate funding strategies and structures. Our investment banking team has access to over 400 institutional investors and a broad base of accredited and retail investors. We provide both deal and non-deal road shows in the U.S. and Europe as well as conferences and management one-on-one meetings.

Our investment banking team is experienced in all capital structures and transaction types as well as effective communication strategies and can customize a complete solution that benefits both the company and its investor base.

Relevant Relationships

BioNovo Inc. Echo Therapeutics, Inc. IsoRay Inc.



2012-05-24-848 SELECT * FROM `master` WHERE CompanyID='13666' AND `Profile_Type` LIKE 'resource' AND `Approved` LIKE 'YES' ORDER BY `Member_Priority` ASC LIMIT 0 , 30